Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
101.86
-2.11 (-2.03%)
Jul 23, 2026, 10:36 AM EDT - Market open
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.98 billion as of July 23, 2026. Its market cap has increased by 24.94% in one year.
Market Cap
6.98B
Enterprise Value
6.76B
1-Year Change
24.94%
Ranking
Category
Stock Price
$101.86
ChartMarket Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $6.98B, an increase of 757.69%. That is a compound annual growth rate of 27.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 6.98B | -2.28% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 8.20B |
| Vaxcyte | 8.01B |
| ImmunityBio | 7.85B |
| TG Therapeutics | 7.65B |
| Mirum Pharmaceuticals | 7.11B |
| Cogent Biosciences | 6.55B |
| Erasca | 6.53B |
| PTC Therapeutics | 6.47B |